BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Long (1Y)
Religare recommends buy on Glenmark Pharma
Glenmark Pharma strategic blueprint implies fairly strong growth over the medium term, but a lot would depend on the R&D execution and its ability to successfully monetise its innovative pipeline, Religare said.